Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates

被引:28
作者
Brueggemeier, SB
Wu, D
Kron, SJ
Palecek, SP
机构
[1] Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA
[2] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA
关键词
D O I
10.1021/bm050257v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe the development of an array-based assay for the molecular level detection of tyrosine kinase activity directly from cellular extracts. Glutathione S-transferase-Crk1 (GST-Crk1) fusion proteins are covalently immobilized into polyacrylamide gel pads via copolymerization of acrylic monomer and acrylic-functionalized GST-Crk1 protein constructs on a polyacrylamide surface. The resulting hydrogels resist nonspecific protein adsorption, permitting quantitative and reproducible determination of Abl tyrosine kinase activity and inhibition, even in the presence of a complex cell lysate mixture. Half-maximal inhibition (IC50) values for imatinib mesylate inhibition of GST-Crk1 (SH3) phosphorylation by v-Abl in a purified system and Bcr-Abl within a K562 cell lysate were determined to be 1.5 and 20 mu M, respectively. Additionally, the protein-acrylamide copolymer arrays detected CML cell levels as low as 15% in a background of Bcr-Abl- leukemic cells and provided the framework for the parallel evaluation of six tyrosine kinase inhibitors. Such a system may have direct application to the detection and treatment of cancers resulting from upregulated tyrosine kinase activity, such as chronic myeloid leukemia (CML). These findings also establish a basis for screening tyrosine kinase inhibitors and provide a framework on which protein-protein interactions in other complex systems can be studied.
引用
收藏
页码:2765 / 2775
页数:11
相关论文
共 56 条
[1]  
Amabile M, 2001, HAEMATOLOGICA, V86, P252
[2]   Toward optimized antibody microarrays:: a comparison of current microarray support materials [J].
Angenendt, P ;
Glökler, J ;
Murphy, D ;
Lehrach, H ;
Cahill, DJ .
ANALYTICAL BIOCHEMISTRY, 2002, 309 (02) :253-260
[3]   Protein microchips: Use for immunoassay and enzymatic reactions [J].
Arenkov, P ;
Kukhtin, A ;
Gemmell, A ;
Voloshchuk, S ;
Chupeeva, V ;
Mirzabekov, A .
ANALYTICAL BIOCHEMISTRY, 2000, 278 (02) :123-131
[4]   Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL [J].
Azam, M ;
Latek, RR ;
Daley, GQ .
CELL, 2003, 112 (06) :831-843
[5]   THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].
BEN-NERIAH, Y ;
DALEY, GQ ;
MESMASSON, AM ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1986, 233 (4760) :212-214
[6]   Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors [J].
Blencke, S ;
Zech, B ;
Engkvist, O ;
Greff, Z ;
Örfi, L ;
Horváth, Z ;
Kéri, G ;
Ullrich, A ;
Daub, H .
CHEMISTRY & BIOLOGY, 2004, 11 (05) :691-701
[7]   Use of protein-acrylamide copolymer hydrogels for measuring protein concentration and activity [J].
Brueggemeier, SB ;
Kron, SJ ;
Palecek, SP .
ANALYTICAL BIOCHEMISTRY, 2004, 329 (02) :180-189
[8]   Antibody arrays for high-throughput screening of antibody-antigen interactions [J].
de Wildt, RMT ;
Mundy, CR ;
Gorick, BD ;
Tomlinson, IM .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :989-994
[9]   Specific targeted therapy of chronic myelogenous leukemia with imatinib [J].
Deininger, MWN ;
Druker, BJ .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :401-423
[10]   Mechanisms of disease - The biology of chronic myeloid leukemia [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
O'Brien, S ;
Kurzrock, R ;
Kantarjian, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :164-172